SARC-F 问卷各项目对泌尿系统癌症大手术患者预后的影响

Kohei Hirose, Shugo Yajima, Ryo Andy Ogasawara, Naoki Imasato, Sao Katsumura, Madoka Kataoka, Yasukazu Nakanishi, Hitoshi Masuda
{"title":"SARC-F 问卷各项目对泌尿系统癌症大手术患者预后的影响","authors":"Kohei Hirose, Shugo Yajima, Ryo Andy Ogasawara, Naoki Imasato, Sao Katsumura, Madoka Kataoka, Yasukazu Nakanishi, Hitoshi Masuda","doi":"10.22540/JFSF-09-201","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to evaluate the association between scores on each item of the SARC-F questionnaire and life expectancy in patients undergoing major surgery for urologic cancer.</p><p><strong>Methods: </strong>This retrospective study included 1018 patients undergoing elective major urologic cancer surgery. All patients completed the SARC-F questionnaire preoperatively. Demographic and clinical data were collected. The primary endpoint was an association between SARC-F scores and overall survival (OS).</p><p><strong>Results: </strong>Of the 1018 patients, the median age was 72 years and 920 (90%) were male. Multivariate analysis revealed four factors significantly and independently associated with shorter OS: assistance with walking score ≥1 (Hazard ratio: HR=2.18, <i>P</i>=0.044), cancer stages ≥ III (HR=7.98, <i>P</i><0.001), high blood loss ≥78 ml or blood transfusion during surgery (HR=4.53, <i>P</i>=0.007 and HR=2.41, <i>P</i>=0.037, respectively).</p><p><strong>Conclusions: </strong>This study found that among the items of the SARC-F questionnaire, assistance with walking was a strong predictor of life expectancy. Incorporating such a simple screening tool into the preoperative assessment would help to ensure more appropriate perioperative care for urologic cancer patients.</p>","PeriodicalId":73754,"journal":{"name":"Journal of frailty, sarcopenia and falls","volume":"9 3","pages":"201-206"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367079/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prognostic Impact of Each Item of the SARC-F Questionnaire in Patients Undergoing Major Surgery for Urologic Cancer.\",\"authors\":\"Kohei Hirose, Shugo Yajima, Ryo Andy Ogasawara, Naoki Imasato, Sao Katsumura, Madoka Kataoka, Yasukazu Nakanishi, Hitoshi Masuda\",\"doi\":\"10.22540/JFSF-09-201\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>We aimed to evaluate the association between scores on each item of the SARC-F questionnaire and life expectancy in patients undergoing major surgery for urologic cancer.</p><p><strong>Methods: </strong>This retrospective study included 1018 patients undergoing elective major urologic cancer surgery. All patients completed the SARC-F questionnaire preoperatively. Demographic and clinical data were collected. The primary endpoint was an association between SARC-F scores and overall survival (OS).</p><p><strong>Results: </strong>Of the 1018 patients, the median age was 72 years and 920 (90%) were male. Multivariate analysis revealed four factors significantly and independently associated with shorter OS: assistance with walking score ≥1 (Hazard ratio: HR=2.18, <i>P</i>=0.044), cancer stages ≥ III (HR=7.98, <i>P</i><0.001), high blood loss ≥78 ml or blood transfusion during surgery (HR=4.53, <i>P</i>=0.007 and HR=2.41, <i>P</i>=0.037, respectively).</p><p><strong>Conclusions: </strong>This study found that among the items of the SARC-F questionnaire, assistance with walking was a strong predictor of life expectancy. Incorporating such a simple screening tool into the preoperative assessment would help to ensure more appropriate perioperative care for urologic cancer patients.</p>\",\"PeriodicalId\":73754,\"journal\":{\"name\":\"Journal of frailty, sarcopenia and falls\",\"volume\":\"9 3\",\"pages\":\"201-206\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367079/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of frailty, sarcopenia and falls\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22540/JFSF-09-201\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of frailty, sarcopenia and falls","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22540/JFSF-09-201","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的我们旨在评估接受泌尿系统癌症大手术的患者在 SARC-F 问卷各项目上的得分与预期寿命之间的关系:这项回顾性研究包括1018名接受泌尿系统癌症大手术的患者。所有患者在术前都填写了 SARC-F 问卷。研究还收集了人口统计学和临床数据。研究的主要终点是SARC-F评分与总生存期(OS)之间的关系:在 1018 名患者中,中位年龄为 72 岁,920 人(90%)为男性。多变量分析显示,四个因素与较短的OS显著且独立相关:协助行走评分≥1(危险比:HR=2.18,P=0.044)、癌症分期≥III(分别为HR=7.98,PP=0.007和HR=2.41,P=0.037):本研究发现,在 SARC-F 问卷的各个项目中,协助行走是预测预期寿命的有力指标。将这样一个简单的筛查工具纳入术前评估将有助于确保为泌尿系统癌症患者提供更合适的围手术期护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prognostic Impact of Each Item of the SARC-F Questionnaire in Patients Undergoing Major Surgery for Urologic Cancer.

Objectives: We aimed to evaluate the association between scores on each item of the SARC-F questionnaire and life expectancy in patients undergoing major surgery for urologic cancer.

Methods: This retrospective study included 1018 patients undergoing elective major urologic cancer surgery. All patients completed the SARC-F questionnaire preoperatively. Demographic and clinical data were collected. The primary endpoint was an association between SARC-F scores and overall survival (OS).

Results: Of the 1018 patients, the median age was 72 years and 920 (90%) were male. Multivariate analysis revealed four factors significantly and independently associated with shorter OS: assistance with walking score ≥1 (Hazard ratio: HR=2.18, P=0.044), cancer stages ≥ III (HR=7.98, P<0.001), high blood loss ≥78 ml or blood transfusion during surgery (HR=4.53, P=0.007 and HR=2.41, P=0.037, respectively).

Conclusions: This study found that among the items of the SARC-F questionnaire, assistance with walking was a strong predictor of life expectancy. Incorporating such a simple screening tool into the preoperative assessment would help to ensure more appropriate perioperative care for urologic cancer patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信